Clinical trials: Bariatric Sleeve Gastrectomy
Obesity
Impact of Extent of Antral Resection on Outcomes of Sleeve Gastrectomy
Laparoscopic sleeve gastrectomy (LSG) is a surgical technique that treats morbid obesity by both restrictive and hormonal action. Consecutive patients with morbid obesity treated by LSG at our department were evaluated.
- Trial name
- LSG (NCT01974388)
- Testing
- LSG started 2 cm from the pylorus, LSG started 6 cm from pylorus
- Where
- Egypt
- Volunteers
- 105 people
- Sponsor
- Mansoura University
Bariatric Surgery Candidate
Endoscopic Management Of Refractory Gastro-cutaneous Fistula After Laparoscopic Sleeve Gastrectomy l
This study included patients who were admitted to investigators' center to do laparoscopic sleeve gastrectomy and complicated by gastro-cutaneous fistula . Cases were collected in the period from December 2019 to march 2021.
- Trial name
- NCT04879667
- Testing
- endoscopic management of gastrocutaneous fistula after laparoscopic sleeve gastrectomy
- Where
- Egypt
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Zagazig University
Bariatric Surgery Candidate, Bariatric Surgical Procedure
Fat Taste Sensory Study
Fat is the most energy dense macronutrient and consuming fat has been positively correlated to obesity. Individuals afflicted with obesity crave fat more frequently, have a higher preference for fatty taste, and consume a higher…
- Trial name
- FaTSS (NCT03540693)
- Testing
- RYGB, SG, LAGB
- Where
- United States
- Volunteers
- 105 people, healthy volunteers welcome
- Sponsor
- University of Illinois at Urbana-Champaign
Sleeve Gastrectomy
Alcohol After Bariatric Surgery 2
The goal of this observational study is to learn how the body processes ingested alcohol and how alcohol affects mood and blood sugar in both men and women after undergoing sleeve gastrectomy.
- Trial name
- ABS2 (NCT06257771)
- Testing
- Alcohol (Ethanol)
- Where
- United States
- Volunteers
- 88 people
- Sponsor
- University of Illinois at Urbana-Champaign
Obesity, Periodontitis
Short-Term Changes in Salivary IL-6, TNF-α, and Periodontal Inflammation Following Sleeve Gastrectomy in Patients With Obesity: A Randomized Controlled Pilot Study
Obesity and periodontitis are chronic inflammatory conditions that may share biological pathways. This pilot randomized controlled study compared adults with obesity and stage I-III periodontitis assigned to laparoscopic sleeve…
- Trial name
- NCT07731412
- Testing
- Laparoscopic Sleeve Gastrectomy, Non-Surgical Obesity Management, Standardized Oral-Hygiene Instructions
- Where
- Romania
- Volunteers
- 32 people
- Sponsor
- George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Obesity, Obesity, Morbid
Endoscopic Metabolic and Bariatric Therapies
This is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.
- Conditions
- Obesity, Obesity, Morbid, Obesity Associated Disorder, Bariatric Surgery Candidate
- Trial name
- EMBTs (NCT05725967)
- Testing
- Primary Obesity Endoscopic Procedures, Endoscopic Revision of Bariatric Surgical Procedures, Bariatric Surgery Procedures
- Where
- United States
- Volunteers
- 5,000 people
- Sponsor
- Christopher C. Thompson, MD, MSc
Gastroesophageal Reflux
Antireflux Efficacy of Hiatal Hernia Repairs in Sleeve Gastrectomy Patients
Gastroesophageal reflux (GR) occurrence or persistence following a sleeve gastrectomy (SG) can be correlated to several factors but it is clear that one of the key factors is a persistent hiatal hernia or laxity of the esophageal…
- Trial name
- NCT04433507
- Testing
- Sleeve gastrectomy, Hiatal Hernia repair
- Where
- Canada
- Volunteers
- 16 people
- Sponsor
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Bariatric Surgery Candidate, Perioperative Complication
Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery
Post-operative nausea and vomiting (PONV) is one of the leading causes of patient morbidity after laparoscopic bariatric surgeries.
- Conditions
- Bariatric Surgery Candidate, Perioperative Complication, Nausea, Vomiting, Postoperative
- Trial name
- PONV (NCT05087615)
- Testing
- Metoclopramide, Ondansetron, Metoclopramide and Ondanteron
- Where
- Iran
- Volunteers
- 130 people, healthy volunteers welcome
- Sponsor
- Shahid Beheshti University of Medical Sciences
Bariatric Surgery Candidate, Obesity, Morbid
Volumetric Pouch Study After Laparoscopic Sleeve Gastrectomy
This study aimed to evaluate Laparoscopic Sleeve Gastrectomy in the treatment of morbidly obese patients pre and post-operatively after 3 months, 6 months, and 1-year follow-up and assess the volumetric changes of the gastric…
- Trial name
- NCT04880902
- Testing
- sleeve gastrectomy
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Kafrelsheikh University
Anemia, Iron Deficiency
Iron Supplement to Improve Iron Status Following Bariatric Surgery
There is a high prevalence of iron deficiency in patients who undergo bariatric surgery and effective therapies are lacking. Thus, there is a critical need for an effective, non-invasive, and inexpensive form of iron…
- Trial name
- NCT02404012
- Testing
- Oral iron supplementation
- Where
- United States
- Volunteers
- 64 people
- Sponsor
- Indiana University
Obesity
Leak Pressure After Reinforcement in Gastric Specimens
The investigators hypothesize that staple line reinforcement will result in a higher leak pressure than a non-reinforced staple line closure in the resected gastric specimens from laparoscopic sleeve gastrectomy.
- Trial name
- NCT02272907
- Testing
- Injection of saline solution into specimen to test bursting pressure.
- Sponsor
- Santa Barbara Cottage Hospital
Bariatric Surgery, Morbid Obesity
Pharmacokinetics of Rivaroxaban After Bariatric Surgery
Data on pharmacokinetics of rivaroxaban after bariatric surgery and in morbid obesity are sparse. The aim of this study is to assess the pharmacokinetic and pharmacodynamic parameters of rivaroxaban, used at a therapeutic…
- Trial name
- ABSORB (NCT04180436)
- Testing
- rivaroxaban 20 mg once daily 8 days
- Where
- France
- Volunteers
- 67 people, healthy volunteers welcome
- Sponsor
- University Hospital, Brest
Bariatric Surgery Candidate, Pain, Postoperative
Autonomic Neural Blockade in Bariatric Surgery
The purpose of this research is to evaluate if autonomic nerve block (ANB- blocking pain and nausea signals) decreases pain and anti-nausea medication requirements as well as the experience of pain/nausea during the first 72…
- Conditions
- Bariatric Surgery Candidate, Pain, Postoperative, Nausea and Vomiting, Postoperative, Opioid Use
- Trial name
- NCT07104825
- Testing
- Intraoperative autonomic neural blockade (ANB), Laparoscopic Standard of Care Abdominal Wall Block
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Endeavor Health
Obesity and Overweight, Nutritional Deficiency
Nutritional Health and Satisfaction After Bariatric Surgery: a Five-Year Retrospective Study
A retrospective study analyzing long-term outcomes of metabolic bariatric surgery (MBS) with a focus on weight loss, nutritional deficiencies, and patient satisfaction over a five-year follow-up.
- Conditions
- Obesity and Overweight, Nutritional Deficiency, Bariatric Surgery
- Trial name
- NCT06664580
- Testing
- Metabolic Bariatric Surgery Procedures
- Volunteers
- 249 people
- Sponsor
- San Raffaele Telematic University
Obesity, Morbid, Weight Gain
Transit Bipartition After Sleeve Gastrectomy
Retrospective analysis of 100 morbidly obese patients who underwent a transit bipartition (TB) procedure ("Single Anastomosis Sleeve Ileal bypass") for inadequate weight loss or weight recidivism after a previous sleeve…
- Conditions
- Obesity, Morbid, Weight Gain, Bariatric Surgery Candidate
- Trial name
- TB-LSG (NCT04782648)
- Testing
- transit bipartition
- Where
- Germany
- Volunteers
- 100 people
- Sponsor
- Ruhr University of Bochum
Morbid Obesity, Metabolic Syndrome X
Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Bariatric surgery is the most effective treatment for morbid obesity. Roux-en-Y gastric bypass (RYGB) is a bariatric procedure with known safety and effectiveness.
- Conditions
- Morbid Obesity, Metabolic Syndrome X, Diabetes Mellitus, Dyslipidemia
- Trial name
- NCT01806506
- Testing
- Laparoscopic sleeve gastrectomy, Roux-en-Y Gastric Bypass
- Where
- Poland
- Volunteers
- 72 people
- Sponsor
- Medical University of Warsaw
Morbid Obesity
OnQ Pain Pump Effectiveness in Post Operative Pain Control in Bariatric Patients
This study will assess the efficacy of OnQ pain catheters in pain reduction in the bariatric surgical population and seeks to identify if a quantifiable improved post-operative course occurs in patients receiving a catheter…
- Trial name
- NCT03159130
- Where
- United States
- Sponsor
- William Beaumont Army Medical Center
Bariatric Surgery Candidate
Short Term Outcome Of Distal Mesogastric Fixation After Laparoscopic Sleeve Gastrectomy;
This study included patients who were admitted to investigator's center to do laparoscopic sleeve gastrectomy . Cases were collected in the period from December 2019 to December 2020.
- Trial name
- NCT04834323
- Testing
- distal mesogastric fixation after sleeve gastrectomy
- Where
- Egypt
- Volunteers
- 84 people
- Sponsor
- Zagazig University
Postoperative Hemorrhage, Obesity
Warm Saline Irrigation Before Omentopexy to Reduce Early Bleeding After Laparoscopic Sleeve Gastrectomy
This prospective randomized clinical trial evaluates whether warming saline irrigation (37-40 °C) applied to the gastric staple line before performing omentopexy during laparoscopic sleeve gastrectomy (LSG) can reduce early…
- Trial name
- WARM-LSG (NCT07475169)
- Testing
- Warm Saline Irrigation, Room Temperature Saline Irrigation
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Ain Shams University
Obesity and Obesity-related Medical Conditions
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
The recent introduction of the new generation of anti-obesity medications (AOMs) will change the future of obesity treatment. These highly effective medications, such as high-dose semaglutide and tirzepatide, are hormone…
- Trial name
- NCT06803888
- Testing
- Bariatric Surgery, Semaglutide, Tirzepatide
- Where
- United States
- Volunteers
- 140 people
- Sponsor
- Ali Aminian